Clovis Oncology Inc reports results for the quarter ended in September - Earnings Summary

Clovis Oncology

03/11/2021 14:11

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly adjusted
loss of 56 cents​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 48 cents per share.
* Revenue fell 2.2% to $37.92 million from a year ago;  analysts
expected $39.45 million. 
* Clovis Oncology Inc's reported EPS for the quarter was a loss
of 56 cents​.
* The mean earnings estimate of analysts had risen by about 6.9%
in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Clovis Oncology Inc shares had risen by 6.7% this quarter and
lost 0.8% so far this year.
* The company reported a quarterly loss of $67.41 million.
* Wall Street's median 12-month price target for Clovis Oncology
Inc is $5.75 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell." 
This summary was machine generated November 3 at 02:11 p.m.
 ​All figures in US dollars unless otherwise stated